COMPATIBILITY STUDIES OF GLIMEPIRIDE WITH SELECTED EXCIPIENTS FOR THE DEVELOPMENT OF EXTENDED RELEASE FORMULATIONS

N Bipul; S Satyabrat

首页> 外文期刊>International Journal of Pharmacy and Biological Sciences >COMPATIBILITY STUDIES OF GLIMEPIRIDE WITH SELECTED EXCIPIENTS FOR THE DEVELOPMENT OF EXTENDED RELEASE FORMULATIONS

【24h】

COMPATIBILITY STUDIES OF GLIMEPIRIDE WITH SELECTED EXCIPIENTS FOR THE DEVELOPMENT OF EXTENDED RELEASE FORMULATIONS

机译：格列美脲与选择的赋形剂之间的相容性研究，以开发扩展的释放配方

获取原文

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

The objective of this study was to detect interaction of Glimepiride with selected extended release excipients by DSC and FT - IR and to develop ER tablet by direct compression method. In the first phase of the study, differential scanning calorimeter (DS

机译：这项研究的目的是通过DSC和FT-IR检测格列美脲与选定的缓释赋形剂的相互作用，并通过直接压片法开发ER片剂。在研究的第一阶段，差示扫描量热仪（DS

著录项

来源
《International Journal of Pharmacy and Biological Sciences》 |2016年第2期|共12页
作者
N Bipul; S Satyabrat;
展开▼
作者单位

展开▼
收录信息
原文格式 PDF
正文语种
中图分类药学;
关键词

相似文献

外文文献
中文文献
专利

1. Compatibility studies between isosorbide mononitrate and selected excipients used in the development of extended release formulations. [J] . Verma RK, Garg S Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis . 2004,第3期

机译：单硝酸异山梨酯与选定的赋形剂在延长释放制剂开发中的相容性研究。
2. Selection of excipients for extended release formulations of glipizide through drug-excipient compatibility testing. [J] . Verma RK, Garg S Journal of Pharmaceutical and Biomedical Analysis: An International Journal on All Drug-Related Topics in Pharmaceutical, Biomedical and Clinical Analysis . 2005,第4期

机译：通过药物-赋形剂相容性测试选择格列吡嗪缓释制剂的赋形剂。
3. SELECTION OF EXCIPIENTS FOR NANOPARTICLES FORMULATIONS OF NATEGLINIDE THROUGH DRUG-EXCIPIENTS COMPATIBILITY STUDY [J] . GOPI GOVINDASAMY, KANNAN KRISHNAMOORTHY, MANAVALAN RAJAPPAN International Journal of Pharmacy and Pharmaceutical Sciences . 2013,第Suppla2期

机译：通过药物-赋形剂相容性研究制备萘乙酸内酯的纳米颗粒制剂的赋形剂
4. VaIproic Acid Extended Release Formulation Development and In-Vitro In-VivoCorrelation (IVIVC) development [C] . George Vamvakas, Chue Yang, Aqeel Fatmi, Annual meeting exposition of the Controlled Release Society . 2009

机译：丙酸缓释制剂开发和体外体内相关性（IVIVC）开发
5. Development and characterization of an extended release formulation of cyclobenzaprine hydrochloride using lipophilic and hydrophilic matrix components by fusion method. [D] . Parisa, Poorna Veera Venkataavinash. 2016

机译：使用亲脂性和亲水性基质组分通过融合方法开发和表征盐酸环苯扎林缓释制剂。
6. Comparative steady-state pharmacokinetic study of an extended-release formulation of itopride and its immediate-release reference formulation in healthy volunteers [O] . Seonghae Yoon, Howard Lee, Tae-Eun Kim, 2014

机译：伊托必利缓释制剂及其速释参考制剂在健康志愿者中的比较稳态药代动力学研究
7. Unveiling the compatibility of eugenol with formulation excipients by systematic drug-excipient compatibility studies [O] . Kannissery Pramod, Chettiyam Veettil Suneesh, Salim Shanavas, 2015

机译：通过系统的药物-赋形剂相容性研究揭示丁香酚与制剂赋形剂的相容性

COMPATIBILITY STUDIES OF GLIMEPIRIDE WITH SELECTED EXCIPIENTS FOR THE DEVELOPMENT OF EXTENDED RELEASE FORMULATIONS

摘要

著录项

相似文献

相关主题

期刊订阅